Double Medical(SZ:002901) Sou Hu Cai Jing·2026-01-28 13:00Core Viewpoint - The stock of Dabo Medical (002901) has shown fluctuations in its trading performance, with a recent closing price of 51.22 yuan, reflecting a decline of 1.31% on January 28, 2026, amidst varying capital flows from different investor categories [1]. Group 1: Stock Performance and Capital Flow - On January 28, 2026, Dabo Medical's stock closed at 51.22 yuan, down 1.31%, with a turnover rate of 1.36% and a trading volume of 39,200 hands, resulting in a transaction amount of 201 million yuan [1]. - The capital flow data on January 28 indicates a net outflow of 4.23 million yuan from institutional investors, accounting for 2.1% of the total transaction amount, while retail investors experienced a net outflow of 1.45 million yuan, representing 0.72% of the total [1]. - Over the past five days, the stock has seen significant fluctuations, with a peak closing price of 51.90 yuan on January 27, 2026, which was a 7.45% increase, followed by a net inflow of 12.99 million yuan from institutional investors on that day [2]. Group 2: Company Financials and Industry Comparison - Dabo Medical's total market capitalization stands at 21.206 billion yuan, significantly higher than the industry average of 11.206 billion yuan, ranking 12th out of 127 companies in the medical device sector [3]. - The company reported a net profit of 425 million yuan, which is substantially higher than the industry average of 208 million yuan, placing it 17th in the industry ranking [3]. - Dabo Medical's gross margin is 71.23%, well above the industry average of 50.94%, indicating strong profitability relative to its peers [3]. - For the first three quarters of 2025, the company achieved a main business revenue of 1.876 billion yuan, reflecting a year-on-year increase of 22.69%, and a net profit growth of 77.03% to 425 million yuan [3].